why choose us

First received: September 23, 2022

Clinical Trial: A Study to Assess the Efficacy and Safety of AXS-05 in Subjects with Alzheimer's Disease Agitation

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Agitation in Patients with Dementia of the Alzheimer's Type

Study Type: INTERVENTIONAL


Official Title: ADVANCE-2: Addressing Dementia Via Agitation-Centered Evaluation 2: a Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-05 for the Treatment of Alzheimer'

Brief Summary: This trial is a multi-center, double-blind, placebo-controlled, randomized study to evaluate the efficacy and safety of AXS-05 compared to placebo for the treatment of agitation associated with Alzheimer's disease.

Read more